Portfolio Alerts Watch List Cart

Pharmaceutical

Refine Search

Product Compare (0)
S
Suven Life Sciences Ltd
Score 68/100• Decent
Suven Life Sciences Ltd shows potential for growth, but faces challenges in valuation and execution risks.
Company’s Health49/100
Valuation 20/100 · PB 35.3217
Technical Avoid
1M -7.723% 6M -34.455% 1Y 14.995%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#46
View details ➜
S
Solara Active Pharma Sciences Ltd
Score 68/100• Decent
Solara Active Pharma Sciences Ltd shows potential for growth, but faces challenges in profitability and market competition.
Company’s Health24/100
Valuation 60/100 · PB 2.395
Technical Avoid
1M 9.829% 6M 16.023% 1Y -20.855%
Confidence100%
Reasonable PB valuation
Weak ROEPromoter pledge present
#47
View details ➜
S
SMS Pharmaceuticals Ltd
Score 68/100• Decent
SMS Pharmaceuticals Ltd shows decent potential with consistent growth, but faces challenges in valuation and liquidity.
Company’s Health66/100
Valuation 40/100 · PB 4.6954
Technical Momentum
1M 8.835% 6M 25.298% 1Y 27.769%
Confidence100%
Low leverage (D/E)
Weak ROEPromoter pledge present
#48
View details ➜
S
Shukra Pharmaceuticals Ltd
Score 68/100• Decent
Shukra Pharmaceuticals Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised for investors.
Company’s Health89/100
Valuation 20/100 · PB 35.6491
Technical Momentum
1M 16.734% 6M 243.125% 1Y 670.482%
Confidence100%
Low leverage (D/E)No promoter pledge
#49
View details ➜
S
Shelter Pharma Ltd
Score 68/100• Decent
Shelter Pharma Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised.
Company’s Health84/100
Valuation 80/100 · PB 1.3767
Technical Avoid
1M -17.127% 6M -12.703% 1Y -33.549%
Confidence100%
Low leverage (D/E)No promoter pledge
#50
View details ➜
S
Samrat Pharmachem Ltd
Score 68/100• Decent
Samrat Pharmachem Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
Company’s Health75/100
Valuation 80/100 · PB 1.1098
Technical Avoid
1M -9.635% 6M -24.168% 1Y -37.425%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#51
View details ➜
R
Rainbow Children's Medicare Ltd
Score 68/100• Decent
Rainbow Children's Medicare Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health92/100
Valuation 20/100 · PB 9.5348
Technical Avoid
1M 1.337% 6M -5.034% 1Y -14.946%
Confidence100%
No promoter pledgeHealthy profit margins
#52
View details ➜
P
Panacea Biotec Ltd
Score 68/100• Decent
Panacea Biotec Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health55/100
Valuation 60/100 · PB 2.6556
Technical Avoid
1M -16.873% 6M -20.156% 1Y -21.957%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#53
View details ➜
M
Mankind Pharma Ltd
Score 68/100• Decent
Mankind Pharma Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
Company’s Health97/100
Valuation 20/100 · PB 6.1739
Technical Avoid
1M -1.839% 6M -8.837% 1Y -17.795%
Confidence100%
No promoter pledgeHealthy profit margins
#54
View details ➜
I
Indraprastha Medical Corporation Ltd
Score 68/100• Decent
Indraprastha Medical Corporation Ltd shows potential but faces challenges in growth consistency and profitability metrics. Caution is advised.
Company’s Health82/100
Valuation 20/100 · PB 7.2341
Technical Avoid
1M -17.538% 6M 14.548% 1Y -2.556%
Confidence100%
Low leverage (D/E)No promoter pledge
#55
View details ➜
E
Emcure Pharmaceuticals Ltd
Score 68/100• Decent
Emcure Pharmaceuticals shows potential for growth, but faces several challenges that could impact its performance.
Company’s Health85/100
Valuation 20/100 · PB 5.8754
Technical Avoid
1M 3.094% 6M 4.557% 1Y 6.919%
Confidence100%
Low leverage (D/E)Decent revenue growth
Promoter pledge present
#56
View details ➜
P
PREVEST DENPRO LTD
Score 68/100• Decent
The stock shows potential but faces challenges in growth consistency and valuation metrics.
Company’s Health98/100
Valuation 20/100 · PB 5.3432
Technical Avoid
1M -8.325% 6M -1.961% 1Y -18.27%
Confidence100%
Low leverage (D/E)No promoter pledge
#57
View details ➜
P
Parnax Lab Ltd
Score 68/100• Decent
Parnax Lab Ltd shows potential in a growing sector but faces significant challenges in growth consistency and profitability metrics.
Company’s Health63/100
Valuation 80/100 · PB 1.7351
Technical Avoid
1M -14.211% 6M 18.008% 1Y -24.837%
Confidence100%
Reasonable PB valuation
Promoter pledge presentThin margins
#58
View details ➜
O
Omkar Pharmachem Ltd
Score 68/100• Decent
Omkar Pharmachem Ltd shows potential but faces several challenges that may hinder growth.
Company’s Health68/100
Valuation 60/100 · PB 2.9998
Technical Avoid
1M 4.775% 6M -6.5% 1Y 0.972%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#59
View details ➜
M
Medicamen Organics Ltd
Score 68/100• Decent
Medicamen Organics Ltd shows potential for growth but faces several challenges that could impact its performance.
Company’s Health94/100
Valuation 100/100 · PB 0.998
Technical Avoid
1M -7.143% 6M -42.414% 1Y -56.522%
Confidence100%
Low leverage (D/E)No promoter pledge
#60
View details ➜
Showing 46 to 60 of 260 (18 Pages)